Abstract
The use of below-the-knee drug-eluting stents for endovascular revascularization in patients with critical limb ischemia (CLI) has been described. Data are lacking regarding use of bioabsorbable-polymer drug-eluting stents (BP-DES) in the infra-geniculate vessels in patients with CLI Rutherford
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
